Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety and efficacy extension of zonisamide monotherapy in newly diagnosed partial epilepsy
2008-001159-23Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of zonisamide in epilepsy (2 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Retention rate. Started Jun 2008; status: completed.
02
Drugs
zonisamide
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2008-001159-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001159-23.